Back to Search
MARK LUNDBLAD, PHARMD
PHARMD
Pharmacist
NPI: 1588277388Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
0202205245(VA)
Research & Publications (20)
Ultrasound versus landmark-based technique for ilioinguinal-iliohypogastric nerve blockade in children: the implications on plasma levels of ropivacaine.
PMID 19372326·Anesth Analg·2009
4-observational
Chronic intermittent L-DOPA treatment induces changes in dopamine release.
PMID 19196428·J Neurochem·2009
7-preclinical
Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice.
PMID 18428668·Curr Protoc Neurosci·2007
7-preclinical
Proteomic analysis of striatal proteins in the rat model of L-DOPA-induced dyskinesia.
PMID 17532790·J Neurochem·2007
7-preclinical
Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model.
PMID 17306893·Behav Brain Res·2007
4-observational
The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration.
PMID 17157933·Behav Brain Res·2007
4-observational
Ultrasound-guided infrapatellar nerve block in human volunteers: description of a novel technique.
PMID 17005509·Br J Anaesth·2006
8-other
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
PMID 16942598·J Neurochem·2006
6-review
Pharmacokinetic interactions between chloroquine, sulfadoxine and pyrimethamine and their bioequivalence in a generic fixed-dose combination in healthy volunteers in Uganda.
PMID 16916298·Afr Health Sci·2006
4-observational
Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats.
PMID 16539687·J Neurochem·2006
7-preclinical
Accumulation of celecoxib with a 7-fold higher drug exposure in individuals homozygous for CYP2C9*3.
PMID 16513453·Clin Pharmacol Ther·2006
3-trial
Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia.
PMID 16256359·Neurobiol Dis·2006
7-preclinical
Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population.
PMID 16025294·Eur J Clin Pharmacol·2005
8-other
Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.
PMID 15899244·Exp Neurol·2005
4-observational
Biosynthesis of epoxyeicosatrienoic acids varies between polymorphic CYP2C enzymes.
PMID 15652503·Biochem Biophys Res Commun·2005
8-other
Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia.
PMID 15474360·Neurobiol Dis·2004
7-preclinical
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function.
PMID 15207268·Neurobiol Dis·2004
4-observational
Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy).
PMID 15056471·Neurobiol Dis·2004
4-observational
MRI of the skeleton in prostate cancer staging.
PMID 12775281·Scand J Urol Nephrol·2003
4-observational
Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia.
PMID 12614340·J Neurochem·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7205 LITTLE RIVER TPKE
ANNANDALE, VA 22003 - Phone
- (703) 256-4030
Quick Facts
- NPI
- 1588277388
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile